Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneovenous shunts in malignant ascites.

J H Helzberg, N J Greenberger

    Digestive Diseases and Sciences
    |November 1, 1985
    PubMed
    Summary

    Peritoneovenous shunts offer effective malignant ascites control in cancer patients. While complications like shunt occlusion and heart failure occur, the procedure successfully manages ascites in most cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note.

    Neurology·2007
    Same author

    Update in gastroenterology.

    Annals of internal medicine·2000
    Same author

    Enzymatic therapy in patients with chronic pancreatitis.

    Gastroenterology clinics of North America·1999
    Same author

    Update in gastroenterology.

    Annals of internal medicine·1999
    Same author

    Significance of retroperitoneal air after endoscopic retrograde cholangiopancreatography with sphincterotomy.

    The American journal of gastroenterology·1999
    Same author

    Update in gastroenterology.

    Annals of internal medicine·1998

    Area of Science:

    • Oncology
    • Gastroenterology
    • Surgical Procedures

    Background:

    • Malignant ascites, often a complication of advanced cancers like hepatocellular carcinoma, significantly impacts patient quality of life.
    • Effective management of malignant ascites is crucial for symptom relief and improving patient outcomes.

    Observation:

    • A case study of a 51-year-old woman with hepatocellular carcinoma demonstrated successful ascites control using a peritoneovenous (LeVeen) shunt.
    • A review of 12 series encompassing 198 patients with malignant ascites was conducted to evaluate shunt efficacy.

    Findings:

    • Peritoneovenous shunts demonstrated efficacy in controlling malignant ascites in 77% of patients reviewed.
    • Complications were observed in 25% of patients, primarily related to shunt occlusion and transient congestive heart failure.

    Implications:

    • Peritoneovenous shunts represent a viable treatment option for managing malignant ascites, offering symptom relief.
    • Further research into mitigating shunt-related complications could enhance the safety and effectiveness of this procedure.

    Related Experiment Videos